Loading asset research
Lunai Bioworks Inc. Common Stock
LNAINasdaq · USD · StocksQuote as of · Exchange session not verified$1.93
-0.52%
Today
LNAI
Loading 1D prices…
Market cap
$8.8M
Volume
28.9K
52w high
$13.2852w low
$1.21Company profile
Lunai Bioworks Inc. Common Stock
Lunai Bioworks Inc., a pre-clinical stage biotechnology company, provides medicine, diagnostics, and biodefense products the United States and the Netherlands. It operates through three segments, RENB, BioSymetrics, and RENC. The company is developing a genetically modified allogeneic dendritic cell therapeutic vaccines, including RENB-DC11 to treat solid tumors primarily for pancreatic tumors; and RENB-DC20 for the treatment of breast cancer. It also develops an artificial intelligence platform technology for early cancer detection and its recurrence that uses a multi-omics approach to search for individual biomarkers that are present even in asymptomatic patients. The company was formerly known as Renovaro Inc. and changed its name to Lunai Bioworks Inc. in August 2025. Lunai Bioworks Inc. is headquartered in Los Angeles, California.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
SUITE 906 LOS ANGELES, CA, United States
Employees
29
Fiscal year end
0630
CIK
1527728
Session & valuation
Open$2.00
Previous close$1.94
Day high$2.20
Day low$1.90
30-day avg. volume38K
Outstanding shares36.3M
Diluted EPS-$0.07
Latest annual period
P/E (trailing)-27.57
P/E (forward)—
Price / book-0.90
Beta0.34
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| ALZNAlzamend Neuro Inc. Common Stock | $8.8M | $0.00 | — | -$2.63 | +0.55% | Hold |
| LGVNLongeveron Inc. Class A Common Stock | $8.9M | $1.2M | -1893.58% | -$1.29 | -3.44% | Buy |
| KALAKALA BIO Inc. Common Stock | $9.2M | $0.00 | — | -$3.31 | -15.00% | Unrated |
| SNGXSoligenix Inc. Common Stock | $8.3M | $0.00 | — | -$2.14 | -2.56% | Unrated |
| TRAWTraws Pharma Inc. Common Stock | $8.3M | $2.8M | +328.67% | $0.82 | 0.00% | Hold |